S100A7 and esophageal squamous cell carcinoma: The results showed that 41% of lung SCCs, 76.6% of esophageal SCCs, 50.6% of cervical SCCs, 80.4% of oral SCCs, 84.8% of skin SCCs and 66.7% of bladder SCCs were positive for S100A7 (Table 1).